Selected research
Industry Growth & Trends
Global Maternal Mental Health Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Maternal Mental Health market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Maternal Mental Health is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Maternal Mental Health is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Maternal Mental Health is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Maternal Mental Health market include Lipocine, Pfizer, Viatris, Bold Health, Glaxo Smith Kline Inc., Alembic Pharmaceuticals Limited, Mallinckrodt, Sage Therapeutics, Inc. and Bausch Health Companies Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Maternal Mental Health market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Maternal Mental Health market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Maternal Mental Health market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Maternal Mental Health.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Maternal Mental Health market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Maternal Mental Health Market by Company
Lipocine
Pfizer
Viatris
Bold Health
Glaxo Smith Kline Inc.
Alembic Pharmaceuticals Limited
Mallinckrodt
Sage Therapeutics, Inc.
Bausch Health Companies Inc.
Magellan Health
Maternal Mental Health Segment by Type
Antidepressants
Interpersonal Psychotherapy
Cognitive Behavioural Therapy
Others
Maternal Mental Health Segment by Application
Clinics
Hospitals
Others
Maternal Mental Health Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Maternal Mental Health market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Maternal Mental Health and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Maternal Mental Health.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Maternal Mental Health companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Antidepressants
- Interpersonal Psychotherapy
- Cognitive Behavioural Therapy
- Others
Applications
- Clinics
- Hospitals
- Others
Companies covered
- Lipocine
- Pfizer
- Viatris
- Bold Health
- Glaxo Smith Kline Inc.
- Alembic Pharmaceuticals Limited
- Mallinckrodt
- Sage Therapeutics, Inc.
- Bausch Health Companies Inc.
- Magellan Health
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Maternal Mental Health Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Maternal Mental Health Market Size by Region (2021-2032)
- 1.4.1 Global Maternal Mental Health Market Size by Region (2021-2026)
- 1.4.2 Global Maternal Mental Health Market Size by Region (2027-2032)
- 1.5 Key Regions Maternal Mental Health Market Size (2021-2032)
- 1.5.1 North America Maternal Mental Health Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Maternal Mental Health Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Maternal Mental Health Market Size Growth Rate (2021-2032)
- 1.5.4 South America Maternal Mental Health Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Maternal Mental Health Market Size Growth Rate (2021-2032)
2 Maternal Mental Health Market by Type
- 2.1 Type Introduction
- 2.1.1 Antidepressants
- 2.1.2 Interpersonal Psychotherapy
- 2.1.3 Cognitive Behavioural Therapy
- 2.1.4 Others
- 2.2 Global Maternal Mental Health Market Size by Type
- 2.2.1 Global Maternal Mental Health Market Size Overview by Type (2021-2032)
- 2.2.2 Global Maternal Mental Health Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Maternal Mental Health Market Size Forecasted by Type (2027-2032)
- 2.3 Global Maternal Mental Health Market Size by Regions
- 2.3.1 North America Maternal Mental Health Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Maternal Mental Health Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Maternal Mental Health Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Maternal Mental Health Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Maternal Mental Health Market Size Breakdown by Type (2021-2026)
3 Maternal Mental Health Market by Application
- 3.1 Type Introduction
- 3.1.1 Clinics
- 3.1.2 Hospitals
- 3.1.3 Others
- 3.2 Global Maternal Mental Health Market Size by Application
- 3.2.1 Global Maternal Mental Health Market Size Overview by Application (2021-2032)
- 3.2.2 Global Maternal Mental Health Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Maternal Mental Health Market Size Forecasted by Application (2027-2032)
- 3.3 Global Maternal Mental Health Market Size by Regions
- 3.3.1 North America Maternal Mental Health Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Maternal Mental Health Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Maternal Mental Health Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Maternal Mental Health Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Maternal Mental Health Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Maternal Mental Health Industry Trends
- 4.2 Maternal Mental Health Industry Drivers
- 4.3 Maternal Mental Health Industry Opportunities and Challenges
- 4.4 Maternal Mental Health Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Maternal Mental Health Revenue (2021-2026)
- 5.2 Global Maternal Mental Health Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Maternal Mental Health Key Company Headquarters & Area Served
- 5.4 Global Maternal Mental Health Company, Product Type & Application
- 5.5 Global Maternal Mental Health Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Maternal Mental Health Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Maternal Mental Health Players Market Share by Revenue in 2025
- 5.6.3 2025 Maternal Mental Health Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Lipocine
- 6.1.1 Lipocine Company Information
- 6.1.2 Lipocine Business Overview
- 6.1.3 Lipocine Maternal Mental Health Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Lipocine Maternal Mental Health Product Portfolio
- 6.1.5 Lipocine Recent Developments
- 6.2 Pfizer
- 6.2.1 Pfizer Company Information
- 6.2.2 Pfizer Business Overview
- 6.2.3 Pfizer Maternal Mental Health Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Pfizer Maternal Mental Health Product Portfolio
- 6.2.5 Pfizer Recent Developments
- 6.3 Viatris
- 6.3.1 Viatris Company Information
- 6.3.2 Viatris Business Overview
- 6.3.3 Viatris Maternal Mental Health Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Viatris Maternal Mental Health Product Portfolio
- 6.3.5 Viatris Recent Developments
- 6.4 Bold Health
- 6.4.1 Bold Health Company Information
- 6.4.2 Bold Health Business Overview
- 6.4.3 Bold Health Maternal Mental Health Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Bold Health Maternal Mental Health Product Portfolio
- 6.4.5 Bold Health Recent Developments
- 6.5 Glaxo Smith Kline Inc.
- 6.5.1 Glaxo Smith Kline Inc. Company Information
- 6.5.2 Glaxo Smith Kline Inc. Business Overview
- 6.5.3 Glaxo Smith Kline Inc. Maternal Mental Health Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Glaxo Smith Kline Inc. Maternal Mental Health Product Portfolio
- 6.5.5 Glaxo Smith Kline Inc. Recent Developments
- 6.6 Alembic Pharmaceuticals Limited
- 6.6.1 Alembic Pharmaceuticals Limited Company Information
- 6.6.2 Alembic Pharmaceuticals Limited Business Overview
- 6.6.3 Alembic Pharmaceuticals Limited Maternal Mental Health Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Alembic Pharmaceuticals Limited Maternal Mental Health Product Portfolio
- 6.6.5 Alembic Pharmaceuticals Limited Recent Developments
- 6.7 Mallinckrodt
- 6.7.1 Mallinckrodt Company Information
- 6.7.2 Mallinckrodt Business Overview
- 6.7.3 Mallinckrodt Maternal Mental Health Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Mallinckrodt Maternal Mental Health Product Portfolio
- 6.7.5 Mallinckrodt Recent Developments
- 6.8 Sage Therapeutics, Inc.
- 6.8.1 Sage Therapeutics, Inc. Company Information
- 6.8.2 Sage Therapeutics, Inc. Business Overview
- 6.8.3 Sage Therapeutics, Inc. Maternal Mental Health Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Sage Therapeutics, Inc. Maternal Mental Health Product Portfolio
- 6.8.5 Sage Therapeutics, Inc. Recent Developments
- 6.9 Bausch Health Companies Inc.
- 6.9.1 Bausch Health Companies Inc. Company Information
- 6.9.2 Bausch Health Companies Inc. Business Overview
- 6.9.3 Bausch Health Companies Inc. Maternal Mental Health Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Bausch Health Companies Inc. Maternal Mental Health Product Portfolio
- 6.9.5 Bausch Health Companies Inc. Recent Developments
- 6.10 Magellan Health
- 6.10.1 Magellan Health Company Information
- 6.10.2 Magellan Health Business Overview
- 6.10.3 Magellan Health Maternal Mental Health Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Magellan Health Maternal Mental Health Product Portfolio
- 6.10.5 Magellan Health Recent Developments
7 North America
- 7.1 North America Maternal Mental Health Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Maternal Mental Health Market Size by Country (2021-2026)
- 7.3 North America Maternal Mental Health Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Maternal Mental Health Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Maternal Mental Health Market Size by Country (2021-2026)
- 8.3 Europe Maternal Mental Health Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Maternal Mental Health Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Maternal Mental Health Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Maternal Mental Health Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Maternal Mental Health Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Maternal Mental Health Market Size by Country (2021-2026)
- 10.3 South America Maternal Mental Health Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Maternal Mental Health Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Maternal Mental Health Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Maternal Mental Health Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst